About this site

The McGuireWoods Healthcare Private Equity Team previously published a multi-part series highlighting some of the more active private equity investors in the healthcare space. Since the original publication, we have seen even more PE investors turn toward healthcare investments, new healthcare-focused funds form, and healthcare PE deal activity continue at a staggering pace. Thus, we have decided to launch this site to highlight investors in a more current format, as part of our ongoing service to the healthcare private equity community. These investors, listed purely in alphabetical order, are funds that primarily focus on growth-stage, buyout and platform funding transactions. The sheer number of investors is a real testament to investors’ views of healthcare as a solid investment play.

Welsh, Carson, Anderson & Stowe

Founded in 1979, WCAS’s investment strategy is deal-size agnostic. Based in New York, the firm targets growth-oriented companies within the healthcare and information/business services industries. Companies in its healthcare portfolio include Concentra, a division of Select Medical and provider of occupational medicine, urgent care, physical therapy and wellness services; K2M, a manufacturer of a portfolio of spine surgery products; U.S. Anesthesia Partners, a physician services organization that provides practice management services to anesthesiologists; and United Surgical Partners International, a provider of outpatient surgery through ambulatory surgery centers and surgical hospitals. Read more about WCAS at www.welshcarson.com

WindRose Health Investors

Founded in 2000 and formerly MTS Health Investors, WindRose pursues control equity investments in healthcare companies. Based in New York, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution. Companies in its portfolio include Celerion Holdings, which provides clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research; AGS Health, a revenue cycle management company providing billing and coding services; MDsave, which provides an online location for consumers to research, compare and purchase medical services; and Vital Decisions, a provider of behavioral counseling services to patients with advanced illness. Read more about WindRose at www.windrose.com

Page 16 of 16